# Evoq Remedies (NSE: EVOQ) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/EVOQ · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹6 Cr, it ranks 4045th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Medical Distribution.

Its return on equity was 0.2% in FY25. Promoters held 0.02% of the company as of 31 Mar 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹6 Cr |
| ROE | 0.2% (FY25) |
| ROCE | 0.3% (FY25) |
| Debt to equity | 0 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹12 Cr | ₹0 Cr |
| FY24 | ₹4 Cr | ₹0 Cr |
| FY23 | ₹20 Cr | ₹2 Cr |
| FY22 | ₹17 Cr | ₹1 Cr |

## Shareholding (31 Mar 2026)

- Promoters: 0.02%
- Non-institutions: 99.98%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Trinity League](https://app.pivotnow.in/stock/TRINITYLEA) | — | ₹8 Cr | — | — |
| [Adline Chem Lab](https://app.pivotnow.in/stock/ADLINE) | — | ₹8 Cr | — | — |
| [Unjha Formula](https://app.pivotnow.in/stock/UNJHAFOR) | — | ₹8 Cr | — | — |
| [Dr Lalchandani](https://app.pivotnow.in/stock/DLCL) | — | ₹7 Cr | — | — |
| [Vivanza Bio](https://app.pivotnow.in/stock/VIVANZA) | — | ₹7 Cr | — | — |
| [DECIPHER LABS](https://app.pivotnow.in/stock/DECIPHER) | — | ₹6 Cr | — | — |

## Questions and answers

### What is the market cap of Evoq Remedies?

Evoq Remedies' market capitalisation is ₹6 Cr (₹6 Cr) at the 22 Oct 2026 close, ranking 4045th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Evoq Remedies?

Return on equity was 0.2% in FY25 and return on capital employed was 0.3% in FY25 (standalone figures).

### Is Evoq Remedies a debt-free company?

Evoq Remedies is close to debt-free: its debt-to-equity ratio was 0 in FY25.

### What is the shareholding pattern of Evoq Remedies?

As of 31 Mar 2026: promoters 0.02%, non-institutions 99.98%.

### Who are Evoq Remedies' competitors?

The listed Pharma & Healthcare companies closest to Evoq Remedies by market cap are Trinity League, Adline Chem Lab, Unjha Formula, Dr Lalchandani, Vivanza Bio and DECIPHER LABS.

### Is Evoq Remedies a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Evoq Remedies' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on EVOQ against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.